Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

NCI-MATCH Data Shows Value of Platform Trials for Patients With Rare Genomically Driven Cancers

Premium

The findings demonstrate the value of multi-cohort platform trials as an option for refractory cancer patients with particularly rare genomic tumor alterations.

Pancreatic Cancer Action Network Launches Adaptive Clinical Trial Platform

PanCAN has partnered with Tempus to provide panel genomic testing for every patient enrolled in the Precision Promise platform study.

Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells

Premium

The newly public company has attracted attention from both investors and competitors for its technology platform used in antibody discovery workflows.

Genuity Science, Ionis Pharmaceuticals Partner on Antisense Therapy Development

Genuity Science, formerly known as WuXi NextCode, will receive a combination of upfront, development milestone, and product royalty payments under the deal.

Genetron Health, DMed Enter Pharma Services Partnership

The firms aim to combine their respective products and expertise to provide comprehensive R&D solutions for drug development in oncology.

Sep 15, 2020

Hexagon Bio Raises $47M in Series A Round

Aug 28, 2020

Freenome Maintains CRC Early Detection Timeline as New Biomarker Discovery Studies Progress

Premium

Aug 24, 2020

Cancer Genetics to Acquire Organoid Startup Stemonix

Aug 13, 2020

Scipher Medicine, Galapagos Sign IBD Drug Development Deal

Aug 13, 2020

Mission Bio Raises $70M in Series C Funding Round

Aug 11, 2020

Broad Institute, One Mind Win $518K Grant for Alzheimer's Disease Research

Aug 11, 2020

Caris Life Sciences, Elevation Oncology Partner on Patient Enrollment for Tumor-Agnostic Drug Trial

Aug 10, 2020

Singapore's Avatamed Raises $1M in Seed Funding

Aug 06, 2020

GeneCentric, Erasmus University to Research RNA Biomarkers, Therapies for Bladder Cancer

Aug 03, 2020

Metabolon, Merck KGaA Form Metabolomics Alliance

Jul 27, 2020

Centogene, Molecular Health Sign Collaboration to Improve Orphan Drug Development

Jul 24, 2020

Curi Bio Acquires Artificial Intelligence Firm Dana Solutions

Jul 22, 2020

Ultivue, OracleBio Collaborate on Tissue Biomarker Analysis Workflow

Jul 15, 2020

ReviveMed, Bristol Myers Squibb to Study Metabolomics for Cancer Immunotherapy

Jul 14, 2020

Merus, Caris Life Sciences Partner to ID NRG1 Fusion-Positive Cancer Patients for Clinical Trial

Jul 08, 2020

Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases

Jul 01, 2020

Celsius Therapeutics Teams With Oxford, Cleveland Clinic, LMU on Single-Cell IBD Research

Jun 24, 2020

Cyclica Raises C$23M in Series B Round

Jun 23, 2020

Illumina Adds Seven International Startups to Business Accelerator Program

Jun 18, 2020

FDA Approves Epizyme's Tazverik, Roche CDx for EZH2-Mutated Follicular Lymphoma Patients

The Scan

Watching the Changes

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

UK Funds Challenge Trial

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

Max Planck, Nature Strike a Deal

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

PNAS Papers on Ancient Tibetan Animals, HNSCC Drug Response, More

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

CAS-CLOVER The clean alternative to CRISPR/Cas9 for gene editing in the drug discovery and development industry

Nov

10

Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

Nov

17

Featured Webinar

Spatial Expression Analyses Elucidates Mechanisms of circRNAs in Cancer

Circular RNAs (circRNAs) have recently gained substantial attention in the cancer research field where most, including the putative oncogene ciRS-7 (CDR1as), have been proposed to function as competitive endogenous RNAs (ceRNAs) by “sponging” specific microRNAs.

Menu

Drug Discovery & Development

What's Popular?